2月27日,云顶新耀一则公告让沉寂已久的专利江湖再起波澜。其原研产品布地奈德肠溶胶囊(耐赋康®)专利维权取得关键进展:广州知识产权法院已于2026年2月26日作出民事裁定书,全面支持公司提出的诉前行为保全申请,并责令相关仿制药企业立即停止侵权行为并停止挂网,该裁定自作出之日起立即执行。截图来源:云顶新耀官微受此利好消息刺激,2月27日云顶新耀股价应声上涨近5%。但这场胜利背后的惊心动魄,远非K线图...
Source Link2月27日,云顶新耀一则公告让沉寂已久的专利江湖再起波澜。其原研产品布地奈德肠溶胶囊(耐赋康®)专利维权取得关键进展:广州知识产权法院已于2026年2月26日作出民事裁定书,全面支持公司提出的诉前行为保全申请,并责令相关仿制药企业立即停止侵权行为并停止挂网,该裁定自作出之日起立即执行。截图来源:云顶新耀官微受此利好消息刺激,2月27日云顶新耀股价应声上涨近5%。但这场胜利背后的惊心动魄,远非K线图...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.